These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27399347)

  • 1. N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population.
    Hedbäck T; Almgren P; Nilsson PM; Melander O
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3437-44. PubMed ID: 27399347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Prosomatostatin and Risk of Vascular Dementia.
    Holm H; Nägga K; Nilsson ED; Ricci F; Cinosi E; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
    Cerebrovasc Dis; 2017; 44(5-6):259-265. PubMed ID: 28854435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.
    Abbasi A; Kieneker LM; Corpeleijn E; Gansevoort RT; Gans RO; Struck J; de Boer RA; Hillege HL; Stolk RP; Navis G; Bakker SJ
    Clin Chem; 2017 Jan; 63(1):278-287. PubMed ID: 28062624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35).
    van Dijk PR; Landman GW; van Essen L; Struck J; Groenier KH; Bilo HJ; Bakker SJ; Kleefstra N
    BMC Endocr Disord; 2015 Apr; 15():19. PubMed ID: 25880900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
    Melander O; Maisel AS; Almgren P; Manjer J; Belting M; Hedblad B; Engström G; Kilger U; Nilsson P; Bergmann A; Orho-Melander M
    JAMA; 2012 Oct; 308(14):1469-75. PubMed ID: 23047361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality.
    Dakhel A; Engström G; Melander O; Acosta S; Fatemi S; Gottsäter A; Zarrouk M
    Angiology; 2021 Jul; 72(6):550-555. PubMed ID: 33504164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proneurotensin Predicts Cardiovascular Disease in an Elderly Population.
    Fawad A; Bergmann A; Struck J; Nilsson PM; Orho-Melander M; Melander O
    J Clin Endocrinol Metab; 2018 May; 103(5):1940-1947. PubMed ID: 29546332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
    Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.
    Januzzi JL; Lyass A; Liu Y; Gaggin H; Trebnick A; Maisel AS; D'Agostino RB; Wang TJ; Massaro J; Vasan RS
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1692-7. PubMed ID: 27312221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
    von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM; Venge P; Lind L
    Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study.
    Hallengren E; Almgren P; Engström G; Hedblad B; Persson M; Suhr J; Bergmann A; Melander O
    J Am Coll Cardiol; 2014 Oct; 64(14):1452-60. PubMed ID: 25277616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
    von Scholten BJ; Reinhard H; Hansen TW; Oellgaard J; Parving HH; Jacobsen PK; Rossing P
    Diabetologia; 2016 Jul; 59(7):1549-1557. PubMed ID: 27033561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy.
    Tada H; Nomura A; Yoshimura K; Itoh H; Komuro I; Yamagishi M; Takamura M; Kawashiri MA
    Circ J; 2020 Feb; 84(3):509-515. PubMed ID: 32023582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus.
    Blanke P; Naoum C; Ahmadi A; Cheruvu C; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Chow BW; Min J; Leipsic J
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1280-1288. PubMed ID: 27568114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.